Update – 26/01/2022
January 26, 2022
January 26, 2022
As of the latest update by the Greek authorities, the total number of confirmed Covid-19 diagnosed cases in Greece 1,830,263. 98 new deaths were reported raising the total number to 22,852. The number of patients treated in intensive care units is currently 653. 17,409 new cases were announced yesterday in Greece. 4,065 of the new cases were found in the Attica region and 2,272 new cases in the Thessaloniki region.
The death rate per million in Greece, which is higher than most European countries and even the US, has caused major concern in the country. 80.4% of intubated patients with coronavirus unvaccinated
A total of 653 coronavirus patients are on ventilators in hospitals on Tuesday, compared to the 655 undergoing the treatment the day before.
Their median age is 66 and 83 percent have an underlying condition and/or are aged 70 or over. Of the total, 525 (80.4%) are unvaccinated or partly vaccinated and 128 (19.6%) are fully vaccinated. Another 3,986 patients have been discharged from ICUs in Greece since the pandemic began.
Data from new studies conducted by the Centers for Disease Control and Prevention (CDC) show that a Covid-19 vaccine booster shot offers significant protection against serious infection from Omicron.
The omicron variant of Covid has become the most dominant strain in the world since it first emerged three months ago in South Africa. The data from the CDC’s three new studies is significant since it represents the first study conducted on Omicron using real-world information, tracking Covid-19 hospitalizations from August 2021 to January 2022, the window of time in which Omicron took over dominance from the Delta variant.
The first study found that two doses of an mRNA Covid vaccine were still 76 percent effective against the Delta variant six months after being administered, but that efficacy dropped to 38 percent against Omicron. A booster shot of the vaccine was found to cause protection against Omicron to rise to 82 percent.
The second study analyzed Covid-19 cases and deaths from April 2021 to December 2021. The study found that two doses of the vaccine cut down the risk of a fatal Covid-19 infection 12-fold and that a booster further reduced that risk to 53-fold.
“In 25 U.S.jurisdictions, decreases in case incidence rate ratios for unvaccinated versus fully vaccinated persons with and without vaccine doses were observed when the Omicron variant emerged in December 2021,” the authors of the study wrote. “Protection against infection and death during the Delta-predominant period against infection during Omicron emergence were higher among booster vaccine recipients, and especially among persons aged 50-64 and >65 years.”
The third study looked exclusively at 70,000 symptomatic Covid cases documented from December 2021 to early January 2022, the period in which Omicron cases surged. The study concluded that people with a booster dose of the vaccine were 66 percent less likely to contract a symptomatic case compared to those who only had two doses.
In more detail, the 17,409 new cases detected per Regional Unit: